Vital Images has filed a 510(k) application with the Food andDrug Administration for a new, more advanced version of its 3-Dimage processing software, according to the company's parent,Bio-Vascular of St. Paul, MN. The new version builds on VitalImages'
Vital Images has filed a 510(k) application with the Food and
Drug Administration for a new, more advanced version of its 3-D
image processing software, according to the company's parent,
Bio-Vascular of St. Paul, MN. The new version builds on Vital
Images' existing 3-D product, VoxelView 2.5, but is faster and
easier to use. The company plans to display the new version at
this year's Radiological Society of North America meeting. Vital
Images has an agreement with ATL of Bothell, WA, to develop 3-D
ultrasound image processing software (SCAN 8/28/96).
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.